Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2018 | |
| Operating Expenses | 70,947 | 51,166 | 48,328 | 28,881 | 7,515 |
| Operating Income | -70,947 | -51,166 | -48,328 | -28,881 | -7,515 |
| Interest Expense | 13 | 163 | 350 | 482 | 90 |
| Other Income | 905 | 157 | 1,115 | 1,188 | 259 |
| Pre-tax Income | -70,055 | -51,172 | -47,563 | -28,175 | -7,346 |
| Net Income Continuous | -70,055 | -51,172 | -47,563 | -28,175 | -7,346 |
| Net Income | $-70,055 | $-51,172 | $-47,563 | $-28,175 | $-7,346 |
| EPS Basic Total Ops | -2.19 | -1.75 | -2.73 | -4.80 | -7.15 |
| EPS Basic Continuous Ops | -2.19 | -1.75 | -2.73 | -4.80 | -7.15 |
| EPS Diluted Total Ops | -2.19 | -1.75 | -2.73 | -4.80 | -7.15 |
| EPS Diluted Continuous Ops | -2.19 | -1.75 | -2.73 | -4.80 | -7.15 |
| EPS Diluted Before Non-Recurring Items | -2.19 | -1.75 | -2.73 | -4.80 | N/A |
| EBITDA(a) | $-70,209 | $-50,074 | $-47,904 | $-28,735 | $-7,430 |